Search research articles
Contact Us
Filters
Showing results (31-40 of 241) with videos related to
Page
of 25
Sort By:
Nature Reviews. Clinical Oncology
|
October 9, 2013
Suitable trial designs and cohorts for preventive breast cancer agents
Kathrin Strasser-Weippl, Paul E Goss
Breast Cancer Research : BCR
|
December 19, 2008
Putative growth characteristics of micrometastatic breast cancer
Ann F Chambers, Paul E Goss
Journal of Mammary Gland Biology and Neoplasia
|
November 1, 2003
Prevention of breast cancer using SERMs and aromatase inhibitors
Kathrin Strassmer-Weippl, Paul E Goss
Cancer
|
November 1, 1990
Familial testicular cancer in five members of a cancer-prone kindred
P E Goss, M A Bulbul
The Oncologist
|
August 2, 2006
Adjuvant hormonal therapy in peri- and postmenopausal breast cancer
Paula D Ryan, Paul E Goss
Oncology (Williston Park, N.Y.)
|
December 12, 1997
Anastrozole: a new selective nonsteroidal aromatase inhibitor
P E Goss, L M Tye
The Journal of Biological Chemistry
|
February 29, 2000
Characterization of a repressor element and a juxtaposed tissue-restricted activator element located on the distal neu gene promoter
T C Suen, P E Goss
The Oncologist
|
February 5, 2008
The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer
Paula D Ryan, Paul E Goss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2004
Prevention strategies with aromatase inhibitors
Paul E Goss, Kathrin Strasser-Weippl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1994
Current perspectives on aromatase inhibitors in breast cancer
P E Goss, K M Gwyn
Page
of 25
Search research articles
Search
Showing results (31-40 of 241) with videos related to
Sort By:
Page
of 25
Nature Reviews. Clinical Oncology
|
October 9, 2013
Suitable trial designs and cohorts for preventive breast cancer agents
Kathrin Strasser-Weippl, Paul E Goss
Breast Cancer Research : BCR
|
December 19, 2008
Putative growth characteristics of micrometastatic breast cancer
Ann F Chambers, Paul E Goss
Journal of Mammary Gland Biology and Neoplasia
|
November 1, 2003
Prevention of breast cancer using SERMs and aromatase inhibitors
Kathrin Strassmer-Weippl, Paul E Goss
Cancer
|
November 1, 1990
Familial testicular cancer in five members of a cancer-prone kindred
P E Goss, M A Bulbul
The Oncologist
|
August 2, 2006
Adjuvant hormonal therapy in peri- and postmenopausal breast cancer
Paula D Ryan, Paul E Goss
Oncology (Williston Park, N.Y.)
|
December 12, 1997
Anastrozole: a new selective nonsteroidal aromatase inhibitor
P E Goss, L M Tye
The Journal of Biological Chemistry
|
February 29, 2000
Characterization of a repressor element and a juxtaposed tissue-restricted activator element located on the distal neu gene promoter
T C Suen, P E Goss
The Oncologist
|
February 5, 2008
The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer
Paula D Ryan, Paul E Goss
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2004
Prevention strategies with aromatase inhibitors
Paul E Goss, Kathrin Strasser-Weippl
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1994
Current perspectives on aromatase inhibitors in breast cancer
P E Goss, K M Gwyn
Page
of 25